Association of IGF-1 Levels With Height From Childhood to Adulthood: An Observational and Mendelian Randomization Study
- 29 September 2025
- journal article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 111 (3) , e651-e658
Abstract
Context: Growth hormone therapy, which increases circulating levels of insulin-like growth factor 1 (IGF-1), effectively enhances adult height in children with idiopathic short stature, although with varying responses. Objective: To explore the question whether normal IGF-1 variation within a population is causally associated with height across childhood and in adulthood. Methods: We used two-sample Mendelian randomization (MR) to assess the causal effect of serum IGF-1 on adult height. Genetic instruments for IGF-1 were derived from a UK Biobank genome-wide association study (GWAS), and their effects on adult height were identified in the GIANT Consortium GWAS, excluding UK Biobank (Non-Hispanic White: N = 1 176 465; African descent: N = 168 191; South Asian: N = 49 032; East Asian: N = 361 369; Hispanic: N = 58 709). Using the Avon Longitudinal Study of Parents and Children (ALSPAC), we investigated cross-sectional and longitudinal associations between measured IGF-1 levels at ages 7 to 11 years or a genetic risk score (GRS) for IGF-1, with repeated height measurements at ages 7 to 17 years, adjusting for sex, body mass index (BMI), and pubertal stage. Results: Inverse-variance weighted MR showed that a 1 SD increase in IGF-1 confers 0.09 SD taller adult height, which persisted after adjusting for childhood BMI. In ALSPAC, both measured IGF-1 levels at ages 7 to 8 years and IGF-1 GRS were positively associated with height at ages 7 to 17 years at both cross-sectional and longitudinal analyses. Conclusion: Our findings suggest that IGF-1 normal variation has small effects on height in childhood and on final adult height.Keywords
Funding Information
- UK Medical Research Council and Wellcome
- University of Bristol provide core
- D.M.
- Sample Logistics and Genotyping Facilities
- Wellcome Sanger Institute and LabCorp
- Career Development
- Researchers in Perinatal and Child Health
- Medical Research Council (MC_UU_00006/2)
- American Diabetes Association
This publication has 33 references indexed in Scilit:
- Insulin-like growth factor binding protein-3 induces senescence by inhibiting telomerase activity in MCF-7 breast cancer cellsScientific Reports, 2023
- A saturated map of common genetic variants associated with human heightNature, 2022
- Genetics of 35 blood and urine biomarkers in the UK BiobankNature Genetics, 2021
- Comparison of the efficacy and safety of recombinant human growth hormone in treating idiopathic short stature and growth hormone deficiency in childrenGrowth Hormone & IGF Research, 2020
- The Actions of IGF-1 in the Growth Plate and Its Role in Postnatal Bone ElongationCurrent Osteoporosis Reports, 2020
- Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseasesNature Genetics, 2018
- Interpreting findings from Mendelian randomization using the MR-Egger methodEuropean Journal of Epidemiology, 2017
- Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median EstimatorGenetic Epidemiology, 2016
- Effect of Growth Hormone Therapy on Height in Children With Idiopathic Short StatureArchives of Pediatrics & Adolescent Medicine, 2002
- Utah Growth Study: Growth standards and the prevalence of growth hormone deficiencyThe Journal of Pediatrics, 1994